Login
- Title:
SGNLVA-002: Single arm, open-label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer
- Document type:
- Meeting Abstract
- Author(s):
- Cortes, J.; Diab, S.; Basho, R. K.; Oliveira, M.; Pluard, T.; Alemany, C.; Brown-Glaberman, U.; Meisel, J.; Boni, V.; Sinha, R.; Garcia Estevez, L.; Ettl, J.; Kuemmel, S.; Manso Sanchez, L. M.; Moon, Y. W.; Villanueva Vazquez, R.; Wuerstlein, R.; Wang, Y.; Wang, Z.; Han, H.
- Journal title abbreviation:
- Ann Oncol
- Year:
- 2020
- Journal volume:
- 31 Suppl 4
- Pages contribution:
- S393-S393
- Fulltext / DOI:
- doi:10.1016/j.annonc.2020.08.459
- Print-ISSN:
- 0923-7534
- TUM Institution:
- Frauenklinik und Poliklinik
BibTeX